PR Hub

Oncolytics Biotech Inc.

Oncolytics Biotech(R) Inc. Announces Completion of Enrollment in Translational Clinical Trial Investigating REOLYSIN(R) in Patients With Metastatic Colorectal Cancer


CALGARY, Alberta, February 23, 2011 - Oncolytics Biotech Inc.
MORE..

Oncolytics Biotech(R) Inc. Collaborators Present Positive Updated U.K. Phase I/II Trial Results in Advanced Solid Cancers With a Focus on the Head and Neck at the ASCO Annual Meeting


CALGARY, Canada, June 7, 2010 - Oncolytics Biotech Inc.
MORE..

Oncolytics Biotech(R) Inc. To Host Conference Call to Discuss Updated U.K. Phase I/II Trial Head and Neck Cancer Data Being Presented at the ASCO Annual Meeting


CALGARY, Canada, June 4, 2010 - Oncolytics Biotech Inc.
MORE..

Oncolytics Biotech(R) Inc. Receives Approval From Belgium FAMHP to Conduct Phase 3 Trial for REOLYSIN(R) in Head and Neck Cancers


CALGARY, Canada, June 1, 2010 - Oncolytics Biotech Inc.
MORE..

Oncolytics Biotech(R) Inc. Announces Opening of Enrollment in Phase 3 Trial for REOLYSIN(R) in Head and Neck Cancers


CALGARY, Canada, May 25, 2010 - Oncolytics Biotech Inc.
MORE..
More News
Older News
S M T W T F S
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
Copyright© 2011 The Gaea Times